Stocks

The table gives an overview of all stocks, alphabetically sorted.

Show advanced options
 CTEK CTEK Apr 25, 2025 12.54 +2.79   
 CTT Systems CTT Apr 25, 2025 204.45 +9.92   
 Curasight CURAS Apr 25, 2025 5.80 +21.09   
 Cyber Security 1 CYB1 Apr 25, 2025 0.00 +5.00   
 Cyclezyme AB CYCLE Apr 25, 2025 15.25 +1.33   
 Dala Energi DE Apr 25, 2025 109.00 +0.93   
 Dedicare B DEDI Apr 25, 2025 44.30 -0.45   
 Desenio DSNO Apr 25, 2025 0.17 +0.90   
 DevPort DEVPB Apr 25, 2025 22.10 -2.21   
 Devyser Diagnostics DVYSR Apr 25, 2025 97.70 -0.20   
 DexTech Medical DEX Apr 25, 2025 4.06 0.00   
 Diadrom Holding DIAH Apr 25, 2025 7.95 0.00   
 Diagonal Bio DIABIO Apr 25, 2025 0.01 0.00   
 Diamyd Medical B DMYDB Apr 25, 2025 7.90 +2.20   
 Dicot Pharma AB DICOT Apr 25, 2025 0.34 +11.15   
 Dignitana DIGN Apr 25, 2025 2.02 -1.46   
 DistIT DIST Apr 25, 2025 2.19 +1.39   
 District Metals Corp. DMXSESDB Apr 25, 2025 2.05 0.00   
 Dividend Sweden AB DIVB Apr 25, 2025 0.21 +5.03   
 Divio Technologies B DIVIOB Apr 25, 2025 0.17 -3.33   
 Diös Fastigheter DIOS Apr 25, 2025 66.30 +1.14   
 Dlaboratory Sweden DLAB Apr 25, 2025 2.66 0.00   
 DOF Group DOFGO Apr 25, 2025 81.15 +0.68   
 Dometic Group DOM Apr 25, 2025 36.30 +4.31   
 Done.ai Group DONE Apr 25, 2025 10.34 +5.73   
 Doro DORO Apr 25, 2025 34.15 -0.29   
 Double Bond Pharmaceutical B DBPB Apr 25, 2025 0.29 +4.76   
 Doxa DOXA Apr 25, 2025 0.33 -2.37   
 Drillcon DRIL Apr 25, 2025 5.58 -3.46   
 Dug Foodtech DUG Apr 25, 2025 1.34 +3.89   
 


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.


Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer. The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.

Titlex

OK
+

Cookie consent

We use cookies to give you a better user experience. If you continue to use the website, you accept this. For further details click here.